Answers are grounded in this paper and cite their sources.
Thermal ablation is an established thyroid-preserving treatment for selected benign nodules and is increasingly studied in low-risk papillary thyroid carcinoma, but its role in primary medullary thyroid carcinoma (MTC) is undefined. Evidence for primary MTC is limited to two case reports; studies of locoregional recurrences show that visible lesions can be controlled, yet progression may occur outside the treated site. This distinction is critical because imaging and biomarkers cannot reliably exclude occult nodal or multifocal disease, focal treatment removes the opportunity for complete histological grading and nodal staging, and postoperative definitions of biochemical cure cannot be transferred to an intact thyroid. We review the rationale and present evidence, identify the principal oncological risks, and propose a deliberately restrictive framework for prospective evaluation in adults who are ineligible for or persistently decline surgery. Initial research should prioritize standardized registries, multicenter feasibility studies, disease-level rather than lesion-level endpoints, and prospective assessment of rescue surgery. Until durable oncological adequacy is demonstrated, thyroidectomy with appropriate nodal management remains the standard of care.
No takes yet. Share an insight, caveat, or question.
Gatta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: